Metagenomi, Inc

Cerus Corporation is a developer of novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs, particularly within the fields of cancer, infectious disease and blood safety. Additionally, the company is employing its proprietary antigens to develop new therapies for cancer, infectious disease and blood safety. In addition, the company has three therapeutic cancer vaccine products in development using its Listeria vaccine platform and other platforms. The company is located in Concord, Calif.

Eureka Therapeutics Inc, located in Emeryville, CA, is a biotechnology company specializing in innovative therapies for cancer treatment. Their cutting-edge technologies, including the E-ALPHA Phage Display Platform and ARTEMIS Cell Receptor Platform, have gained recognition in the scientific community and have been published in numerous scientific publications. With a strong focus on T-cell therapy, Eureka Therapeutics aims to revolutionize cancer treatment by developing personalized therapies that harness the power of the patient's own immune system. Led by their experienced Chief Financial Officer, Alexa Willson, the company benefits from her extensive background in corporate finance and strategy, as well as her expertise in capital raising and mergers and acquisitions.Generated from the website